STOCK TITAN

Cencora (COR) director Lori Ryerkerk granted 557 restricted stock units

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Ryerkerk Lori reported acquisition or exercise transactions in this Form 4 filing.

Cencora, Inc. director Lori Ryerkerk reported receiving an equity award of 557 shares of common stock in the form of restricted stock units. The units were granted for no cash consideration and will vest 100% on the first anniversary of the grant date.

Following this award, Ryerkerk’s directly held common stock equivalent position increased to 1,073 shares, reflecting her updated ownership after the grant and before any future vesting or settlement events.

Positive

  • None.

Negative

  • None.
Insider Ryerkerk Lori
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 557 $359.28 $200K
Holdings After Transaction: Common Stock — 1,073 shares (Direct)
Footnotes (1)
  1. [object Object]
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Ryerkerk Lori

(Last) (First) (Middle)
1 W. FIRST AVENUE

(Street)
CONSHOHOCKEN PA 19428

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Cencora, Inc. [ COR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/05/2026 A 557 A $359.28 1,073(1) D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Grant of restricted stock units received for no consideration and vests 100% on the first anniversary of the date of the grant.
Remarks:
/s/ Elizabeth S. Campbell, attorney-in-fact for Lori J. Ryerkerk 03/09/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Cencora (COR) report for Lori Ryerkerk?

Cencora reported that director Lori Ryerkerk received a grant of 557 restricted stock units tied to common stock. The award was received for no cash consideration and represents an equity-based compensation grant rather than an open-market stock purchase or sale.

How many Cencora (COR) shares did Lori Ryerkerk acquire in this Form 4?

Lori Ryerkerk acquired 557 restricted stock units representing Cencora common stock. These units were granted as an award, not bought in the market, and increased her directly held position to a total of 1,073 common stock equivalents following the reported transaction.

What are the vesting terms of Lori Ryerkerk’s new Cencora (COR) restricted stock units?

The 557 restricted stock units granted to Lori Ryerkerk vest 100% on the first anniversary of the grant date. This means the entire award becomes fully vested at once after one year, assuming the applicable service or other conditions are satisfied by that time.

Did Lori Ryerkerk pay cash for the Cencora (COR) restricted stock unit grant?

No, Lori Ryerkerk did not pay cash for this grant. The footnote explains the 557 restricted stock units were “received for no consideration,” indicating they were awarded as part of her compensation rather than purchased in an open-market transaction.

What is Lori Ryerkerk’s Cencora (COR) share position after this Form 4 transaction?

After the reported grant, Lori Ryerkerk’s directly held common stock equivalent position is 1,073 shares. This total reflects the addition of the 557 restricted stock units awarded in the transaction, as disclosed in the Form 4 ownership figures following the grant.